Myelodysplastic syndromes trials in Russia

5 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor

  Where

  Saint Petersburg

  Age

  18 years to 70 years

  People

  60

  Run by

  St. Petersburg State Pavlov Medical University

  See details and how to joinNCT07238712
• Phase 2/3Taking people
  Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis

  Where

  Moscow

  Age

  1 day to 21 years

  People

  50

  Run by

  Federal Research Institute of Pediatric Hematology, Oncology and Immunology

  See details and how to joinNCT06756152
• Phase 2Taking people
  Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen

  Where

  Saint Petersburg

  Age

  18 years to 75 years

  People

  88

  Run by

  St. Petersburg State Pavlov Medical University

  See details and how to joinNCT06532084
• Phase 2Taking people
  Vitamin A and D Supplementation in Allogeneic HCT

  Where

  Saint Petersburg

  Age

  18 years and over

  People

  220

  Run by

  St. Petersburg State Pavlov Medical University

  See details and how to joinNCT06508099
• Phase 2Taking people
  BeFluBu vs FluBuRux Conditioning in Haploidentical HCT

  Where

  Saint Petersburg

  Age

  18 years to 75 years

  People

  220

  Run by

  St. Petersburg State Pavlov Medical University

  See details and how to joinNCT06477549